DelMar Pharmaceuticals, Inc. (DMPWW)의 가격은 얼마입니까?

DelMar Pharmaceuticals, Inc. (DMPWW)의 가격은 $0.005입니다.

DelMar Pharmaceuticals, Inc. (DMPWW)의 시가 총액은 무엇입니까?

DelMar Pharmaceuticals, Inc. (DMPWW)의 시가 총액은 $1.74K입니다.

DelMar Pharmaceuticals, Inc. (DMPWW) 영업이익률

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

연도	영업이익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

영업이익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	영업이익률	영업이익률 차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	38.97%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Lonza Group AG LONN.SW	0.00%	-	CH
UCB S.A. UCB.BR	31.23%	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	-	KR

회사

영업이익률

영업이익률 차이

국가